Trial data: Chinese mRNA Covid booster stronger against Omicron than Sinovac

Published: Jun 2, 2022 9:15 AM

A Covid-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology triggered a stronger antibody response against the Omicron variant of the coronavirus as a booster dose than Sinovac's shot, clinical trial data showed.

The result for Walvax's ARCoV candidate, which is yet to be peer-reviewed, comes as competition for the Covid-19 booster market intensifies in China, where more than...

Chinese Omicron-specific mRNA Covid vaccine to be trialled in UAE

CanSinoBIO's mRNA Covid-19 vaccine candidate cleared for trials in China

China sticks with mRNA Covid-19 shot development amid uncertainties

China's potential mRNA Covid-19 vaccine weaker against Omicron - study

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: